Post-hoc analyses of a large, randomized clinical trial have revealed the potential advantages associated with electronic ...

A new study published in the Stroke journal revealed a crucial link between early fibrinogen depletion coagulopathy (FDC) and ...

National Institute of Neurological Disorders and Stroke (NINDS) trial of tissue plasminogen activator for acute ischaemic ...

Citing a low hemorrhage rate and other issues, one expert says the results should be replicated before changing practice.

Older Black patients on Medicare in the United States experience disparities in stroke care access and outcomes, compared with White patients.

Intravenous thrombolysis in patients hospitalized for cervical artery dissection-related acute ischemic stroke increases the likelihood of home discharge.

For patients with acute ischemic stroke due to large-vessel occlusion who present within 4.5 hours, intravenous tenecteplase ...

Halving the number of times vital signs and neurological function are checked in low-risk patients after treatment for acute ischaemic stroke does not compromise care or recovery, according to new ...

One advantage touted for tenecteplase is its speed, being administered as a single bolus in 5 seconds rather than the 60 ...

New research provides further evidence that thrombolysis benefits select patients with acute ischemic stroke up to 24 hours after symptom onset. In the HOPE trial, administration of intravenous ...

It has brought intravenous thrombolysis into the era of multiple agent options and opportunities of thrombolysis at late time windows. "It is very fortunate that our team has been a major force in ...